Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Biogen Idec reports death of patient on its MS pill
Clinical proteomics of enervated neurons.
PML in a patient treated with fumaric acid.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Multiple sclerosis review.
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
The cell biology of CNS myelination.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Results from Two Phase III Studies Added to U.S. Label of Genzyme’s Aubagio
Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas.
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study.
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
Neurological involvement in Primary Sjögren Syndrome.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].
Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
24th Biennial Meeting ISN/ASN 2013
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Central fatigue in multiple sclerosis: a review of the literature.
Headwaters of the zebrafish -- emergence of a new model vertebrate.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.

Pages